Trulieve Cannabis earnings and DEA registration shift the conversation
Trulieve Cannabis (TRLV) just paired a return to quarterly profitability with fresh DEA registrations for its medical marijuana dispensaries, reshaping how investors may think about both its earnings profile and regulatory footing.
Trulieve Cannabis has seen momentum build over 2026, with a 1-year total shareholder return of 59.8% and a year to date share price return of 27.47% despite a softer 7 day share price move. That…